Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Illumina To Sequence 100,000 U.K. Genomes
by Alex Scott
August 11, 2014
| A version of this story appeared in
Volume 92, Issue 32
The U.K. government has partnered with Illumina, a gene-sequencing technology firm, in a four-year project to decode 100,000 human genomes. The goal of the project, which the U.K. calls the biggest of its kind, is to advance genetic research in cancer and rare diseases. Illumina will provide infrastructure and expertise. The U.K. government will put more than $200 million into the project, with Illumina investing $270 million and the Wellcome Trust investing $45 million. The U.K. has already secured its first 1,000 volunteers from the public.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter